GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Cyclically Adjusted Revenue per Share

Huadong Medicine Co (SZSE:000963) Cyclically Adjusted Revenue per Share : ¥20.07 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Huadong Medicine Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥5.949. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥20.07 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Huadong Medicine Co's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Huadong Medicine Co was 22.00% per year. The lowest was 7.10% per year. And the median was 18.05% per year.

As of today (2024-06-08), Huadong Medicine Co's current stock price is ¥31.37. Huadong Medicine Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥20.07. Huadong Medicine Co's Cyclically Adjusted PS Ratio of today is 1.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Huadong Medicine Co was 3.56. The lowest was 1.12. And the median was 2.23.


Huadong Medicine Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Huadong Medicine Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Cyclically Adjusted Revenue per Share Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.83 16.06 17.41 18.74 19.74

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.01 19.19 19.55 19.74 20.07

Competitive Comparison of Huadong Medicine Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's Cyclically Adjusted PS Ratio falls into.



Huadong Medicine Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Huadong Medicine Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.949/115.2271*115.2271
=5.949

Current CPI (Mar. 2024) = 115.2271.

Huadong Medicine Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.949 98.200 3.460
201409 3.244 98.900 3.780
201412 3.028 99.000 3.524
201503 3.335 99.900 3.847
201506 3.310 99.500 3.833
201509 3.694 100.500 4.235
201512 3.582 100.600 4.103
201603 3.654 102.200 4.120
201606 7.073 101.400 8.037
201609 7.620 102.400 8.575
201612 3.721 102.600 4.179
201703 4.086 103.200 4.562
201706 3.967 103.100 4.434
201709 4.207 104.100 4.657
201712 3.643 104.500 4.017
201803 4.479 105.300 4.901
201806 4.280 104.900 4.701
201809 4.503 106.600 4.867
201812 4.188 106.500 4.531
201903 5.547 107.700 5.935
201906 4.883 107.700 5.224
201909 5.360 109.800 5.625
201912 4.468 111.200 4.630
202003 4.914 112.300 5.042
202006 4.608 110.400 4.809
202009 5.051 111.700 5.210
202012 4.676 111.500 4.832
202103 5.084 112.662 5.200
202106 4.733 111.769 4.879
202109 5.000 112.215 5.134
202112 4.936 113.108 5.028
202203 5.104 114.335 5.144
202206 5.295 114.558 5.326
202209 5.521 115.339 5.516
202212 5.633 115.116 5.638
202303 5.779 115.116 5.785
202306 5.866 114.558 5.900
202309 5.716 115.339 5.710
202312 5.832 114.781 5.855
202403 5.949 115.227 5.949

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Huadong Medicine Co  (SZSE:000963) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Huadong Medicine Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=31.37/20.07
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Huadong Medicine Co was 3.56. The lowest was 1.12. And the median was 2.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Huadong Medicine Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.
Executives
He Ru Fen Supervisors
Hu Bao Zhen Supervisors
Zhou Shun Hua Executives
Shao Ling Min Supervisors
Wan Ling Ling Executives
Fu Hang Director
Yue Jin Director
Chen Bo Secretary Dong
Qin Yun Supervisors
Li Bang Liang Directors, executives
Zhou Jin Bao Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines